CRISPR THERAP. - Buy on daily chart - target 182 $
Dear traders and followers
the CRISPR stock price closed above the down trend line and formed an inverse head and shoulder pattern on the daily chart. Market is within an strong up trend and reversed several times from 120 $ area. We're looking for a market buy on Monday because this stock could reach the target within a short time frame.
Feel free to leave a comment or to share your ideas in the comments section
Please hit the like button if you share or like this idea.
Follow us and stay up to date/ don't miss new ideas
Thanks for your support!
the CRISPR stock price closed above the down trend line and formed an inverse head and shoulder pattern on the daily chart. Market is within an strong up trend and reversed several times from 120 $ area. We're looking for a market buy on Monday because this stock could reach the target within a short time frame.
Feel free to leave a comment or to share your ideas in the comments section
Please hit the like button if you share or like this idea.
Follow us and stay up to date/ don't miss new ideas
Thanks for your support!
הערה
long term view on weekly chartהערה
We will see a very strong up move If the next weekly candle close above the yellow 20D EMATarget after breakout above ATH seems crazy but this company is a medical game changer and wort at least 50B $ -current valuation is near 8B $
עסקה פעילה
עסקה סגורה: הגיע לסטופ
The analyses provided are for informational purposes only and do not constitute financial advice or recommendations to buy or sell anything. The information presented is based on personal research and interpretation.
The analyses provided are for informational purposes only and do not constitute financial advice or recommendations to buy or sell anything. The information presented is based on personal research and interpretation.
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.